account_num,net_change,tag,tag_depth,cik
645,127282000.0,CashAndCashEquivalentsAtCarryingValue,3,842023_BIO-TECHNE CORP
577,157197000.0,CashCashEquivalentsAndShortTermInvestments,4,842023_BIO-TECHNE CORP
59,-3491000.0,AllowanceForDoubtfulAccountsReceivableCurrent,3,842023_BIO-TECHNE CORP
207,216415000.0,AccountsNotesAndLoansReceivableNetCurrent,4,842023_BIO-TECHNE CORP
320,216415000.0,ReceivablesNetCurrent,3,842023_BIO-TECHNE CORP
455,169464000.0,InventoryNet,2,842023_BIO-TECHNE CORP
868,570996000.0,AssetsCurrent,2,842023_BIO-TECHNE CORP
2764,-24878000.0,ContractWithCustomerLiabilityCurrent,3,842023_BIO-TECHNE CORP
802,18715000.0,AssetImpairmentCharges,1,842023_BIO-TECHNE CORP
2673,-38518000.0,EmployeeRelatedLiabilitiesCurrent,2,842023_BIO-TECHNE CORP
1781,-11682000.0,NonoperatingGainsLosses,1,842023_BIO-TECHNE CORP
229,216415000.0,AccountsReceivableNetCurrent,3,842023_BIO-TECHNE CORP
260,169464000.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,842023_BIO-TECHNE CORP
1455,-11682000.0,GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee,1,842023_BIO-TECHNE CORP
375,69074000.0,ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost,2,842023_BIO-TECHNE CORP
2676,-5250000.0,BusinessCombinationContingentConsiderationLiabilityCurrent,4,842023_BIO-TECHNE CORP
825,18715000.0,GoodwillAndIntangibleAssetImpairment,2,842023_BIO-TECHNE CORP
3315,-5000000.0,BusinessCombinationContingentConsiderationLiabilityNoncurrent,4,842023_BIO-TECHNE CORP
3809,-73551000.0,AccumulatedOtherComprehensiveIncomeLossNetOfTax,2,842023_BIO-TECHNE CORP
1133,18715000.0,RestructuringSettlementAndImpairmentProvisions,3,842023_BIO-TECHNE CORP
2089,2599696000.0,Assets,1,842023_BIO-TECHNE CORP
2398,-27120000.0,AccountsPayableCurrent,2,842023_BIO-TECHNE CORP
2347,-42761000.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,842023_BIO-TECHNE CORP
2737,-12500000.0,LongTermDebtAndCapitalLeaseObligationsCurrent,3,842023_BIO-TECHNE CORP
2638,-12500000.0,DebtCurrent,2,842023_BIO-TECHNE CORP
3017,-865000.0,OtherLiabilitiesCurrent,2,842023_BIO-TECHNE CORP
3154,-141163000.0,LiabilitiesCurrent,2,842023_BIO-TECHNE CORP
3303,-370000000.0,LongTermDebtAndCapitalLeaseObligations,2,842023_BIO-TECHNE CORP
3379,-93267000.0,OperatingLeaseLiabilityNoncurrent,3,842023_BIO-TECHNE CORP
3796,-203847000.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,842023_BIO-TECHNE CORP
3645,-573847000.0,LiabilitiesNoncurrent,2,842023_BIO-TECHNE CORP
3465,-715010000.0,Liabilities,1,842023_BIO-TECHNE CORP
3661,-1573000.0,CommonStockValue,3,842023_BIO-TECHNE CORP
1732,553257000.0,IntangibleAssetsNetExcludingGoodwill,2,842023_BIO-TECHNE CORP
1711,870542000.0,Goodwill,1,842023_BIO-TECHNE CORP
2091,2028700000.0,AssetsNoncurrent,2,842023_BIO-TECHNE CORP
1368,223571000.0,PropertyPlantAndEquipmentNet,4,842023_BIO-TECHNE CORP
2041,283354000.0,OtherAssetsNoncurrent,2,842023_BIO-TECHNE CORP
1827,1423799000.0,IntangibleAssetsNetIncludingGoodwill,2,842023_BIO-TECHNE CORP
2710,-24878000.0,DeferredRevenueCurrent,2,842023_BIO-TECHNE CORP
1634,97976000.0,OperatingLeaseRightOfUseAsset,2,842023_BIO-TECHNE CORP
3834,-1246612000.0,RetainedEarningsAccumulatedDeficit,1,842023_BIO-TECHNE CORP
3383,-94607000.0,DeferredIncomeTaxLiabilitiesNet,2,842023_BIO-TECHNE CORP
3494,-10973000.0,OtherLiabilitiesNoncurrent,2,842023_BIO-TECHNE CORP
3733,-715052000.0,AdditionalPaidInCapitalCommonStock,2,842023_BIO-TECHNE CORP
171,270265000.0,CostOfGoodsAndServicesSold,2,842023_BIO-TECHNE CORP
144,270265000.0,CostOfRevenue,1,842023_BIO-TECHNE CORP
491,69074000.0,ResearchAndDevelopmentExpense,2,842023_BIO-TECHNE CORP
581,87789000.0,OperatingCostsAndExpenses,2,842023_BIO-TECHNE CORP
110,-835382000.0,RevenueFromContractWithCustomerExcludingAssessedTax,2,842023_BIO-TECHNE CORP
2603,-835382000.0,NoninterestIncome,1,842023_BIO-TECHNE CORP
757,27920000.0,OtherAssetsCurrent,2,842023_BIO-TECHNE CORP
2877,-18168000.0,AccruedIncomeTaxesCurrent,2,842023_BIO-TECHNE CORP
2841,-18168000.0,TaxesPayableCurrent,2,842023_BIO-TECHNE CORP
3853,-759000.0,MinorityInterest,1,842023_BIO-TECHNE CORP
2431,179000.0,NetIncomeLossAttributableToNoncontrollingInterest,1,842023_BIO-TECHNE CORP
2552,-15641000.0,AccruedLiabilitiesCurrent,2,842023_BIO-TECHNE CORP
3750,-715052000.0,AdditionalPaidInCapital,1,842023_BIO-TECHNE CORP
281,29915000.0,ShortTermInvestments,1,842023_BIO-TECHNE CORP
2903,-209779000.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,842023_BIO-TECHNE CORP
3316,-1889686000.0,StockholdersEquity,1,842023_BIO-TECHNE CORP
3260,-1889686000.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,842023_BIO-TECHNE CORP
3917,-2599696000.0,LiabilitiesAndStockholdersEquity,2,842023_BIO-TECHNE CORP
232,-565117000.0,GrossProfit,1,842023_BIO-TECHNE CORP
601,291624000.0,SellingGeneralAndAdministrativeExpense,3,842023_BIO-TECHNE CORP
1112,360698000.0,OperatingExpenses,1,842023_BIO-TECHNE CORP
1205,-11682000.0,InvestmentIncomeNonoperating,2,842023_BIO-TECHNE CORP
2130,-45924000.0,NonoperatingIncomeExpense,1,842023_BIO-TECHNE CORP
2149,-250343000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,842023_BIO-TECHNE CORP
2257,-250343000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,842023_BIO-TECHNE CORP
2399,40385000.0,IncomeTaxExpenseBenefit,1,842023_BIO-TECHNE CORP
1820,-290728000.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,842023_BIO-TECHNE CORP
1077,-209958000.0,ProfitLoss,2,842023_BIO-TECHNE CORP
1912,-209779000.0,NetIncomeLoss,1,842023_BIO-TECHNE CORP
2590,-209779000.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,842023_BIO-TECHNE CORP
2716,-12500000.0,LongTermDebtCurrent,2,842023_BIO-TECHNE CORP
1264,-204419000.0,OperatingIncomeLoss,1,842023_BIO-TECHNE CORP
